OIM
BHVN

Oracle Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Oracle Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,240,932
Closed -$181M – 34
2022
Q2 		$181M Sell
1,240,932
-820,470
-40% -$105M 54.93% 1
2022
Q1 		$244M Sell
2,061,402
-14,000
-0.7% -$1.75M 48.33% 1
2021
Q4 		$286M Sell
2,075,402
-48,653
-2% -$6.19M 40.64% 1
2021
Q3 		$295M Buy
2,124,055
+41,500
+2% +$5.18M 36.73% 1
2021
Q2 		$202M Sell
2,082,555
-40,716
-2% -$3.3M 27.86% 1
2021
Q1 		$145M Sell
2,123,271
-25,000
-1% -$2.02M 21.73% 1
2020
Q4 		$184M Buy
2,148,271
+73,471
+4% +$6.23M 23.07% 2
2020
Q3 		$135M Buy
2,074,800
+63,100
+3% +$4.14M 17.77% 2
2020
Q2 		$147M Buy
2,011,700
+140,957
+8% +$7.5M 18.66% 2
2020
Q1 		$63.7M Sell
1,870,743
-52,547
-3% -$2.4M 18.91% 2
2019
Q4 		$105M Buy
1,923,290
+143,415
+8% +$7.1M 19.66% 3
2019
Q3 		$74.3M Buy
1,779,875
+106,925
+6% +$4.52M 18.26% 4
2019
Q2 		$73.3M Buy
1,672,950
+651,558
+64% +$36.7M 15.76% 4
2019
Q1 		$52.6M Buy
1,021,392
+846,857
+485% +$36.6M 11.19% 4
2018
Q4 		$6.45M Buy
+174,535
New +$6.29M 2% 9

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Oracle Investment Management's BHVN Position: Q3 2022 in Review

Oracle Investment Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 1,240,932 shares — an estimated $181M sold.

Oracle Investment Management first reported a position in BHVN in Q4 2018 and held it in 15 quarters. The position peaked at $295M in Q3 2021. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Oracle Investment Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Oracle Investment Management sold 1,240,932 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $181M.
  • Oracle Investment Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2018 and held it in 15 quarters.
  • Oracle Investment Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $295M in Q3 2021.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Oracle Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.